It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks:

Neurocrine Biosciences: "This is one of those stocks that were just like the ones that got bids today. And if you own a stock just for takeover, you could get hurt. Let's be cool, this thing has gotten too hot."